AMN HEALTHCARE INC (AMN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for AMN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| AMN | Director; Independent Board Chair | 65 | ["Finance/Audit","Healthcare Industry","C-Suite Leadership","Legal/Risk Management","Other Public Company Board Experience","Extensive board leadership experience","Institutional knowledge of the Company","Experience executing oversight responsibilities","Fosters a productive relationship with the CEO","Committed to long-term shareholder value","Promotes independent oversight"] | ["Talent and Compensation Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DXCM | Lead Independent Director; Chair | 64 | ["audit committee financial expert"] | ["Audit Committee"] | 2025 |
| ENTA | Lead Director | 64 | ["Chief Financial Officer and Executive Vice President of Tocagen, Inc.", "Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc.", "Vice President, Finance and Chief Financial Officer of Amylin", "management positions with Intermark, Inc. and Triton Group Ltd.", "Audit Manager with Ernst & Young", "interim CFO of Biocept, Inc.", "considerable audit and financial experience in the biotechnology and healthcare sectors"] | [] | 2025 |
Biography sourced from the proxy statement filing.
Mark G. Foletta Independent Board Chair Mr. Foletta has served as the Board Chair since February 2025 and has served on the AMN Board since 2012. The Board selected Mr. Foletta to serve as its independent Chair because he: Has extensive board leadership experience that effectively allows the Chair to lead our Board by keeping it focused on key areas of oversight, coordinating across committees and facilitating effective communication among directors and the Company s executive management; Possesses institutional knowledge of the Company through many different industry cycles and has experience executing oversight responsibilities under myriad operating environments, market conditions and management teams; Fosters a productive relationship between the Board and the Company s CEO by providing a sounding board with candid, constructive feedback from the Board to the Company s executive management team; Is deeply committed to our values and mission while driving long-term shareholder value; Promotes independent oversight of the Company and partners with the Talent and Compensation Committee to oversee the performance and compensation of our CEO; Demonstrated acumen in acting as an independent spokesperson for the Company to our shareholders.